Prescribing Proton Pump Inhibitors
Author:
- 1 March 2012
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 72 (4) , 437-445
Abstract
Proton pump inhibitors (PPIs) are among the most widely used agents in the world. The prevalence of reflux disease is increasing, as is the incidence of oesophageal adenocarcinoma, a complication...Keywords
This publication has 58 references indexed in Scilit:
- Withdrawing PPI Therapy After Healing Esophagitis Does Not Worsen Symptoms or Cause Persistent Hypergastrinemia: Analysis of Dexlansoprazole MR Clinical Trial DataAmerican Journal of Gastroenterology, 2011
- Do proton pump inhibitors decrease calcium absorption?Journal of Bone and Mineral Research, 2010
- Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control studyPharmacoepidemiology and Drug Safety, 2010
- Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: A randomized, crossover, controlled clinical trialJournal of Bone and Mineral Research, 2010
- Medication Usage and the Risk of Neoplasia in Patients With Barrett's EsophagusClinical Gastroenterology and Hepatology, 2009
- Proton pump inhibitors and risk of gastric cancer: a population-based cohort studyBritish Journal of Cancer, 2009
- Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older AdultsCalcified Tissue International, 2008
- Incidence of Adenocarcinoma of the Esophagus Among White Americans by Sex, Stage, and AgeJNCI: Journal of the National Cancer Institute, 2008
- Use of Proton Pump Inhibitors and the Risk of Community-Acquired PneumoniaArchives of internal medicine (1960), 2007
- Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive DrugsJAMA, 2004